Mycobacterium avium subsp. paratuberculosis is the established causative agent of Johne's disease in ruminants. The hypothesis that this organism might also be involved as a cause of the chronic inflammation of the intestines of patients with Crohn's disease was first reported in 1913, but due to the extreme difficulty of culturing this organism by standard techniques, the initial hypothesis was never clearly confirmed. A survey of the United Kingdom Ministry of Agriculture, Food and Fisheries revealed the presence of M. avium subsp. paratuberculosis in 10 of 31 raw milk samples and in 6 pasteurized milk samples (1) . In 1984, Chiodini (4) reported on the isolation of mycobacterial spheroplasts from patients with Crohn's disease. In 10 years, only 5% of tissue from people with Crohn's disease allowed growth of M. avium subsp. paratuberculosis when tissue samples were inoculated into the appropriate medium (15) . Only recently, due to the development of molecular biology-based tools, such as the application of PCR based on the amplification of insertion sequence IS900 (IS900 PCR) to the detection of M. avium subsp. paratuberculosis directly in resected tissue samples, several studies have reported on the presence of the microorganism in a large number of people with Crohn's disease (2, 3, 6, 7, 9, 10, 13, 14) . However, some investigators could not observe the presence of M. avium subsp. paratuberculosis by PCR (3, 8, 17) . Discrepancies and experimental difficulties have surrounded PCR detection of M. avium subsp. paratuberculosis, primarily due to the paucibacillary form of the disease and the complexity of the cell wall of this bacterium (5, 12) . Detection of M. avium subsp. paratuberculosis by in situ hybridization has been reported previously in animal tissues or by use of beef samples injected with M. avium subsp. paratuberculosis spheroplasts (11, 12) . No method for the localization of this type of microorganism in tissue samples has previously been available. Recently, different investigators have reported on the detection of M. avium subsp. paratuberculosis in 40% of diseased tissues from patients with Crohn's disease by an adapted in situ hybridization technique (7, 10) .
Tissue samples. Patient's were diagnosed with Crohn's disease on the basis of clinical presentation (depending on the site of inflammation), fistula formation, transmural inflammation and deep ulceration, thickening of the bowel wall, and the presence of noncaseating granulomas (present in 40 to 60% of the patients). We analyzed 48 different paraffin-embedded intestinal tissue sections (22 ileum, 14 colon, 6 rectum, 1 stomach, and 5 duodenum samples) from 33 different patients with Crohn's disease by IS900 PCR and by in situ hybridization with a biotinylated probe of 284 bp (Table 1) . Granulomas were detected in 25 (52%) samples ( Table 1) . As a control, 20 paraffin-embedded tissue samples from patients with another intestinal bowel disease (ulcerative colitis) and 20 paraffinembedded tissue samples from patients without intestinal bowel disease were analyzed; moreover, other tissue controls such as Caco2 intestinal epithelial cells were hybridized with the IS900 probe. Hybridization control reactions, in which a 150-bp internal fragment of IS6110 (specific for Mycobacterium tuberculosis) was used as a probe, were also performed with all positive tissues and the controls; the probe was obtained as reported previously (16) .
Probe preparation. Briefly, the probe used was a 284-bp internal fragment of IS900 obtained by PCR amplification of M. avium subsp. paratuberculosis chromosomal DNA with primers p89 (5Ј-CGTCGGGTATGGCTTTCATGTGGTTGC TGTG-3Ј) and p92 (5Ј-CGTCGTTGGCCACCCGCTGCGA GAGCAAT-3Ј). The primers were used at concentrations of 0.2 mol each; and the reaction was performed in a total volume of 50 l containing 2.5 U of Taq polymerase, 20 mM Tris (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , and 200 M deoxynucleoside triphosphates (Gibco BRL, Life Technology, Paisley, United Kingdom). The reaction mixtures were overlaid with 1 drop of paraffin oil and were then incubated for 2 min at 94°C, followed by 35 cycles of 94°C for 1 min, 62°C for 1 min, and 72 for 1 min, with a final extension at 70°C for 5 min. The amplification products were visualized after electrophoresis at 90 V for 90 min in a 1.8% Methaphore agarose gel (FMC Bioproducts, Rockland, Maine) and staining of the gel with ethidium bromide.
In situ hybridization. The expected DNA fragment was purified from the gel by using the GFX DNA gel band purification kit (Amersham Pharmacia Biotech Inc., Piscataway, N.J.) The probe was then biotinylated with the Bioprime DNA labeling system (Gibco BRL, Gaithersburg, Md.), and in situ hybridization was carried out with an in situ hybridization system (Gibco BRL) with deparaffinized tissue sections that had previously been treated with proteinase K (100 g/ml) for 30 min at 37°C according to the manufacturer's suggestions.
Ziehl-Neelsen staining was performed as described previously (16) .
DNA extraction and PCR amplification. DNA extraction was performed as reported previously (16) . Embedded paraffin tissues were deparaffinized with xylene as reported previously (14) . PCR was performed with primers p89 and p92 under the same conditions described above.
Forty-eight tissue samples from Crohn's disease patients were analyzed by the in situ hybridization technique with IS900 as a probe; 35 of them were positive. Examples of hybridizations are shown in Fig. 1A and B. As controls, 20 resected intestinal tissue specimens from patients without intestinal bowel disease, 20 tissue samples from patients with another intestinal bowel disease (ulcerative colitis), and Caco2 intestinal epithelial cells were investigated by the in situ hybridization technique. All of them were negative. To avoid possible falsepositive hybridization or nonspecific phosphatase activity, the samples positive by IS900 PCR were tested with the IS6110 probe by the in situ hybridization technique; all of them were negative. Moreover, two slides were prepared for all of the tissue samples tested; one of them was stained by the ZiehlNeelsen method. None of the tissue samples analyzed showed the presence of acid-fast bacilli. One of the causes could be the paucibacillary form of the disease and probably the presence of cell wall-deficient forms of bacteria. The IS900 PCR was performed with all 48 samples to search for the presence of M. avium subsp. paratuberculosis DNA. None of the samples generated specific amplified bands by IS900 PCR, indicating that the sensitivity of the method when it is applied to paraffinembedded tissue is somewhat low. The negative results of the PCR experiments could also be due to the fragmentation of DNA, frequently reported in paraffin-embedded tissue, whereas in situ hybridization retains the ability to hybridize with the fragmented DNA target (8, 9) .
Several samples were obtained from the same patient after several years. Most of the samples from the same patient generated the same result. For instance, samples 7 (ileum), 8 (colon), and 9 (rectum) from patient C-M were all negative (Table 1) . For three patients, patient B-MG (samples 1 and 2), patient M-S (samples 18, 19, and 20), and patient O-E (samples 21 and 22), discordant results were found among the samples analyzed (Table 1) . 
a Thirty-five samples were positive by in situ hybridization, and 25 samples were positive for granulomas. b *, **, and°indicate the same patient.
Different techniques have been used to detect M. avium subsp. paratuberculosis in patients with Crohn's disease: culture, culture followed by PCR, PCR applied to resected bowel tissue, PCR applied to tissues embedded in paraffin, and recently, in situ hybridization with paraffin-embedded tissues (7, 8, 10, 13, 14, 15) .
The reduced sensitivity of PCR can result from the inefficient extraction of the mycobacteria from the sample when small numbers of organisms are involved or may be the consequence of the presence of PCR inhibitors (8, 9, 17) . Moreover, DNA fragmentation may occur during the detection of DNA from paraffin-embedded tissues, causing the failure of target amplification. Our negative IS900 PCR results are in agreement with the results obtained by other researchers (17) . The in situ hybridization technique was adapted to detect cell wall-defective mycobacteria in tissue specimens (10) . The investigators used a digoxigenin-labeled DNA probe to detect the IS900 sequence in tissues from 40% of Crohn's disease patients with granulomas (7, 10) . A similar localization was observed in tissue from animals with Johne's disease (12) .
Our results showed the presence of M. avium subsp. paratuberculosis DNA in more than 70% of the diseased tissue samples from patients with Crohn's disease analyzed. Other investigators, who used the same method, reported that 40% of granulomas were positive (10) . Our data support the hypothesis that infection may be caused by cell wall-defective M. avium subsp. paratuberculosis since no bacteria were detected by Ziehl-Neelsen staining (9) . It is also true that the bacteria are present in small numbers, and it may be difficult for the observer to find them in clinical samples. Multiple samples from the same patients were also analyzed. The results generated were consistent; in most cases, samples from the same patient generated the same result. IS900 hybridization was detected for 72% (18 of 25) of granuloma-positive samples (Table 1) , whereas IS900 hybridization was found for 73.9% (17 of 23) of nongranuloma-positive samples (Table 1) . IS900 probe hybridization was localized in granuloma-like cells (as shown in Fig. 1 ) and around Lieberkühn crypts, whereas Hulten et al. (10) did not report positive hybridization in granulomas. At this point, we cannot establish whether the presence of these bacterial forms is the cause of tissue inflammation or whether the bacteria found a comfortable environment in the altered tissue.
In conclusion, the in situ hybridization technique rather than Zhiel-Neelsen staining or IS900 PCR may be suggested as a means of evaluating clinical samples from patients for the presence of M. avium subsp. paratuberculosis.
